Development and testing of a business process efficiency scale

This study examines the significance of business processes in achieving performance. The objectives of the study are twofold. The first section focuses on developing and validating a business process efficiency scale. Prior literature informs the initial items that comprise the efficiency scale. After developing the prototype scale, the authors then approached local and foreign experts in the field for feedback on individual items. Omitting some items incorporated the expert advice, along with modifying other items to fit with the local culture. We subsequently examined the impact of business process efficiency on employee performance. Using simple random sampling, the research team distributed 252 survey questionnaires to the attendees of a workshop arranged by a local university for its employees. Analysis of 103 valid questionnaires reveals the inefficiency of the overall business processes in the organization. The results of the study show that business process efficiency has a significant impact on employee performance

Development and testing of a business process efficiency scale

This study examines the significance of business processes in achieving performance. The objectives of the study are twofold. The first section focuses on developing and validating a business process efficiency scale. Prior literature informs the initial items that comprise the efficiency scale. After developing the prototype scale, the authors then approached local and foreign experts in the field for feedback on individual items. Omitting some items incorporated the expert advice, along with modifying other items to fit with the local culture. We subsequently examined the impact of business process efficiency on employee performance. Using simple random sampling, the research team distributed 252 survey questionnaires to the attendees of a workshop arranged by a local university for its employees. Analysis of 103 valid questionnaires reveals the inefficiency of the overall business processes in the organization. The results of the study show that business process efficiency has a significant impact on employee performance

Some α − ϕ-Fuzzy Cone Contraction Results with Integral Type Application

In this paper, we define α-admissible and α-ϕ-fuzzy cone contraction in fuzzy cone metric space to prove some fixed point theorems. Some related sequences with contraction mappings have been discussed. Ultimately, our theoretical results have been utilized to show the existence of the solution to a nonlinear integral equation. +is application is also illustrative of how fuzzy metric spaces can be used in other integral type operators.Scopu

Deep eutectic solvent-mediated synthesis of ceria nanoparticles with the enhanced yield for photocatalytic degradation of flumequine under UV-C

© 2019 Elsevier Ltd This study investigated the use of a deep eutectic solvent (DES) for promoting the yield and stability of ceria nanoparticles used for the degradation of flumequine (FLU) under UV-C irradiation. The characterization by Fourier transform infrared spectroscopy, X-ray diffraction spectroscopy, Raman spectroscopy, scanning electron microscopy, energy-dispersive X-ray spectroscopy, high resolution transmission electron microscopy, thermogravimetric analysis, and BET surface area analysis revealed the synthesis of highly stable, highly crystalline, and mesoporous ceria nanoparticles using DES which led to the high removal, i.e., 50 % and 94 % of FLU using DES-Ceria and UV-C/DES-Ceria, respectively. Removal of FLU by the UV-C mediated ceria nanoparticles was due to [rad]OH and thus factors that influenced the reactivity and yield of [rad]OH retarded the removal efficiency of FLU. The pH of aqueous solution affected the removal of FLU by the photocatalysts and removal of FLU was inhibited at highly alkaline and acidic pH. The degradation pathways of FLU were established from the pattern of its degradation and nature of the degradation products. Acute and chronic toxicities of FLU as well as its products were measured. The photocatalyst synthesized in DES was found to be environmentally benign and showed significant potential in the remediation of FLU

Synthesis of nitrogen-doped Ceria nanoparticles in deep eutectic solvent for the degradation of sulfamethaxazole under solar irradiation and additional antibacterial activities

© 2020 Elsevier B.V. In this study, highly crystalline, mesoporous, small sized, stable, and efficient nitrogen-doped (N-doped) Ceria nanoparticles were synthesized using deep eutectic solvent (DES) and used for the photocatalytic degradation of sulfamethaxazole (SMX), a widely used human medication and emerging water contaminant. The N-doped Ceria resulted in 96% removal of SMX versus 59% by Ceria under solar irradiation at 150 min time using [SMX]0 = 10 mg/L and [Ceria]0 = [N-doped Ceria]0 = 0.5 g/L. The solar irradiation of the photocatalysts produced [rad]OH which was proved with electron spin resonance (ESR) spectroscopy and radical scavenger studies and the resulting [rad]OH caused the degradation of SMX. The [rad]OH showed high second-order rate constant with SMX, e.g., 4.9 × 109 M−1 s−1. The photocatalytic degradation of SMX was influenced by pH, concentrations of SMX and photocatalysts, inorganic anions, and natural organic matter. The kinetics of the photocatalytic degradation of SMX was found to be pseudo-first-order. The SMX degradation resulted into several products which were identified by UPLC-MS/MS and the resulting products were used to establish degradation pathways of SMX. The synthesized Ceria and N-doped Ceria also showed good antimicrobial activities towards Staphylococcus aureus and Escherichia coli. The treatment of SMX showed high reusability of N-doped Ceria, low leaching of cerium ions into reaction solution, and high decline in toxicity of SMX which suggests high potential of the synthesized nanoparticles towards SMX degradation

Worldwide Patterns of Ancestry, Divergence, and Admixture in Domesticated Cattle

The domestication and development of cattle has considerably impacted human societies, but the histories of cattle breeds have been poorly understood especially for African, Asian, and American breeds. Using genotypes from 43,043 autosomal single nucleotide polymorphism markers scored in 1,543 animals, we evaluate the population structure of 134 domesticated bovid breeds. Regardless of the analytical method or sample subset, the three major groups of Asian indicine, Eurasian taurine, and African taurine were consistently observed. Patterns of geographic dispersal resulting from co-migration with humans and exportation are recognizable in phylogenetic networks. All analytical methods reveal patterns of hybridization which occurred after divergence. Using 19 breeds, we map the cline of indicine introgression into Africa. We infer that African taurine possess a large portion of wild African auroch ancestry, causing their divergence from Eurasian taurine. We detect exportation patterns in Asia and identify a cline of Eurasian taurine/indicine hybridization in Asia. We also identify the influence of species other than Bos taurus in the formation of Asian breeds. We detect the pronounced influence of Shorthorn cattle in the formation of European breeds. Iberian and Italian cattle possess introgression from African taurine. American Criollo cattle are shown to be of Iberian, and not African, decent. Indicine introgression into American cattle occurred in the Americas, and not Europe. We argue that cattle migration, movement and trading followed by admixture have been important forces in shaping modern bovine genomic variation.Comment: 38 pages, 15 figures. Various changes made to respond to peer reviews. Mostly, arguments were clarified and additional f-statistics were adde

Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019

Background: The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time is essential to this effort. This study assesses the current sex-specific HIV burden in 204 countries and territories and measures progress in the control of the epidemic. Methods: To estimate age-specific and sex-specific trends in 48 of 204 countries, we extended the Estimation and Projection Package Age-Sex Model to also implement the spectrum paediatric model. We used this model in cases where age and sex specific HIV-seroprevalence surveys and antenatal care-clinic sentinel surveillance data were available. For the remaining 156 of 204 locations, we developed a cohort-incidence bias adjustment to derive incidence as a function of cause-of-death data from vital registration systems. The incidence was input to a custom Spectrum model. To assess progress, we measured the percentage change in incident cases and deaths between 2010 and 2019 (threshold >75% decline), the ratio of incident cases to number of people living with HIV (incidence-to-prevalence ratio threshold <0·03), and the ratio of incident cases to deaths (incidence-to-mortality ratio threshold <1·0). Findings: In 2019, there were 36·8 million (95% uncertainty interval [UI] 35·1–38·9) people living with HIV worldwide. There were 0·84 males (95% UI 0·78–0·91) per female living with HIV in 2019, 0·99 male infections (0·91–1·10) for every female infection, and 1·02 male deaths (0·95–1·10) per female death. Global progress in incident cases and deaths between 2010 and 2019 was driven by sub-Saharan Africa (with a 28·52% decrease in incident cases, 95% UI 19·58–35·43, and a 39·66% decrease in deaths, 36·49–42·36). Elsewhere, the incidence remained stable or increased, whereas deaths generally decreased. In 2019, the global incidence-to-prevalence ratio was 0·05 (95% UI 0·05–0·06) and the global incidence-to-mortality ratio was 1·94 (1·76–2·12). No regions met suggested thresholds for progress. Interpretation: Sub-Saharan Africa had both the highest HIV burden and the greatest progress between 1990 and 2019. The number of incident cases and deaths in males and females approached parity in 2019, although there remained more females with HIV than males with HIV. Globally, the HIV epidemic is far from the UNAIDS benchmarks on progress metrics. Funding: The Bill & Melinda Gates Foundation, the National Institute of Mental Health of the US National Institutes of Health (NIH), and the National Institute on Aging of the NIH

Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019

Background: The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time is essential to this effort. This study assesses the current sex-specific HIV burden in 204 countries and territories and measures progress in the control of the epidemic. Methods: To estimate age-specific and sex-specific trends in 48 of 204 countries, we extended the Estimation and Projection Package Age-Sex Model to also implement the spectrum paediatric model. We used this model in cases where age and sex specific HIV-seroprevalence surveys and antenatal care-clinic sentinel surveillance data were available. For the remaining 156 of 204 locations, we developed a cohort-incidence bias adjustment to derive incidence as a function of cause-of-death data from vital registration systems. The incidence was input to a custom Spectrum model. To assess progress, we measured the percentage change in incident cases and deaths between 2010 and 2019 (threshold >75% decline), the ratio of incident cases to number of people living with HIV (incidence-to-prevalence ratio threshold <0·03), and the ratio of incident cases to deaths (incidence-to-mortality ratio threshold <1·0). Findings: In 2019, there were 36·8 million (95% uncertainty interval [UI] 35·1–38·9) people living with HIV worldwide. There were 0·84 males (95% UI 0·78–0·91) per female living with HIV in 2019, 0·99 male infections (0·91–1·10) for every female infection, and 1·02 male deaths (0·95–1·10) per female death. Global progress in incident cases and deaths between 2010 and 2019 was driven by sub-Saharan Africa (with a 28·52% decrease in incident cases, 95% UI 19·58–35·43, and a 39·66% decrease in deaths, 36·49–42·36). Elsewhere, the incidence remained stable or increased, whereas deaths generally decreased. In 2019, the global incidence-to-prevalence ratio was 0·05 (95% UI 0·05–0·06) and the global incidence-to-mortality ratio was 1·94 (1·76–2·12). No regions met suggested thresholds for progress. Interpretation: Sub-Saharan Africa had both the highest HIV burden and the greatest progress between 1990 and 2019. The number of incident cases and deaths in males and females approached parity in 2019, although there remained more females with HIV than males with HIV. Globally, the HIV epidemic is far from the UNAIDS benchmarks on progress metrics. Funding: The Bill & Melinda Gates Foundation, the National Institute of Mental Health of the US National Institutes of Health (NIH), and the National Institute on Aging of the NIH